| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prenatal Diagnosis | 39 | 2025 | 1268 | 5.300 |
Why?
|
| Fetal Diseases | 24 | 2024 | 914 | 3.140 |
Why?
|
| Aneuploidy | 17 | 2023 | 578 | 2.630 |
Why?
|
| Hypoplastic Left Heart Syndrome | 18 | 2020 | 595 | 1.900 |
Why?
|
| Pregnancy | 139 | 2025 | 30260 | 1.840 |
Why?
|
| Ultrasonography, Prenatal | 40 | 2020 | 1774 | 1.760 |
Why?
|
| Aortic Valve Stenosis | 21 | 2022 | 2023 | 1.700 |
Why?
|
| Down Syndrome | 8 | 2020 | 915 | 1.640 |
Why?
|
| Chromosome Aberrations | 9 | 2020 | 1774 | 1.530 |
Why?
|
| Fetal Therapies | 12 | 2020 | 101 | 1.510 |
Why?
|
| Fetal Heart | 15 | 2024 | 281 | 1.420 |
Why?
|
| Genetic Testing | 18 | 2025 | 3595 | 1.390 |
Why?
|
| Congenital Abnormalities | 8 | 2020 | 704 | 1.370 |
Why?
|
| Genetic Diseases, Inborn | 6 | 2023 | 605 | 1.350 |
Why?
|
| Pregnancy Outcome | 26 | 2022 | 2966 | 1.230 |
Why?
|
| Chromosome Disorders | 9 | 2021 | 498 | 1.140 |
Why?
|
| Prenatal Care | 16 | 2023 | 1160 | 1.040 |
Why?
|
| Hypertension, Pregnancy-Induced | 3 | 2024 | 532 | 1.020 |
Why?
|
| Preimplantation Diagnosis | 3 | 2022 | 143 | 0.960 |
Why?
|
| Obstetrics | 6 | 2023 | 680 | 0.930 |
Why?
|
| Pre-Eclampsia | 8 | 2021 | 1261 | 0.930 |
Why?
|
| Reproductive Techniques, Assisted | 6 | 2015 | 501 | 0.880 |
Why?
|
| Gestational Age | 32 | 2021 | 3609 | 0.880 |
Why?
|
| Fetal Growth Retardation | 6 | 2015 | 591 | 0.830 |
Why?
|
| Pregnancy Complications | 18 | 2015 | 2975 | 0.830 |
Why?
|
| Mosaicism | 6 | 2017 | 481 | 0.790 |
Why?
|
| Sex Chromosome Aberrations | 3 | 2022 | 116 | 0.780 |
Why?
|
| Stillbirth | 5 | 2020 | 381 | 0.780 |
Why?
|
| Karyotyping | 11 | 2022 | 1178 | 0.750 |
Why?
|
| Amniocentesis | 2 | 2018 | 116 | 0.720 |
Why?
|
| Fertilization in Vitro | 7 | 2022 | 1306 | 0.700 |
Why?
|
| Smith-Lemli-Opitz Syndrome | 1 | 2020 | 46 | 0.680 |
Why?
|
| Societies | 1 | 2020 | 106 | 0.680 |
Why?
|
| Channelopathies | 1 | 2020 | 32 | 0.670 |
Why?
|
| Postpartum Period | 3 | 2024 | 1205 | 0.660 |
Why?
|
| Nuchal Translucency Measurement | 4 | 2023 | 59 | 0.650 |
Why?
|
| Maternal-Fetal Exchange | 3 | 2020 | 453 | 0.650 |
Why?
|
| Catheterization | 10 | 2011 | 1425 | 0.640 |
Why?
|
| Hernia, Umbilical | 3 | 2009 | 102 | 0.610 |
Why?
|
| Alcohol Drinking | 12 | 2011 | 4040 | 0.600 |
Why?
|
| Pregnancy Trimester, First | 6 | 2016 | 919 | 0.590 |
Why?
|
| Vein of Galen Malformations | 3 | 2023 | 57 | 0.580 |
Why?
|
| Pregnancy Proteins | 3 | 2015 | 225 | 0.570 |
Why?
|
| Genomic Imprinting | 3 | 2015 | 326 | 0.560 |
Why?
|
| Female | 146 | 2025 | 396112 | 0.560 |
Why?
|
| 22q11 Deletion Syndrome | 1 | 2017 | 18 | 0.550 |
Why?
|
| Heart Defects, Congenital | 13 | 2024 | 4697 | 0.550 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 3 | 2015 | 561 | 0.540 |
Why?
|
| Sex Chromosomes | 3 | 2023 | 102 | 0.540 |
Why?
|
| Pregnancy-Associated Plasma Protein-A | 2 | 2014 | 59 | 0.540 |
Why?
|
| Cordocentesis | 1 | 2016 | 10 | 0.530 |
Why?
|
| Gynecology | 5 | 2023 | 535 | 0.510 |
Why?
|
| Pulmonary Atresia | 2 | 2014 | 159 | 0.490 |
Why?
|
| Spouses | 3 | 2006 | 288 | 0.460 |
Why?
|
| Troponin | 1 | 2018 | 533 | 0.450 |
Why?
|
| Reproductive History | 1 | 2015 | 210 | 0.440 |
Why?
|
| alpha-Fetoproteins | 4 | 1998 | 226 | 0.440 |
Why?
|
| Chorionic Gonadotropin, beta Subunit, Human | 1 | 2014 | 83 | 0.440 |
Why?
|
| Fetus | 9 | 2023 | 1870 | 0.440 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2015 | 360 | 0.430 |
Why?
|
| Beckwith-Wiedemann Syndrome | 3 | 2009 | 44 | 0.420 |
Why?
|
| DNA | 9 | 2016 | 7202 | 0.420 |
Why?
|
| Placenta | 4 | 2017 | 1728 | 0.420 |
Why?
|
| Cardiology | 1 | 2024 | 1702 | 0.410 |
Why?
|
| Comparative Genomic Hybridization | 2 | 2015 | 476 | 0.410 |
Why?
|
| Humans | 155 | 2025 | 765968 | 0.400 |
Why?
|
| Patient Transfer | 1 | 2019 | 790 | 0.400 |
Why?
|
| Infant, Newborn | 37 | 2023 | 26346 | 0.390 |
Why?
|
| Twins | 2 | 2011 | 341 | 0.390 |
Why?
|
| Diagnostic Errors | 3 | 2017 | 1275 | 0.380 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2017 | 790 | 0.380 |
Why?
|
| Pregnancy, High-Risk | 2 | 2018 | 121 | 0.370 |
Why?
|
| Chromosome Deletion | 2 | 2015 | 1385 | 0.370 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2014 | 469 | 0.360 |
Why?
|
| Genetic Counseling | 4 | 2021 | 634 | 0.360 |
Why?
|
| Pregnancy, Multiple | 2 | 2011 | 216 | 0.350 |
Why?
|
| Term Birth | 3 | 2016 | 140 | 0.350 |
Why?
|
| Ventricular Remodeling | 1 | 2018 | 1272 | 0.340 |
Why?
|
| Toluene | 3 | 1997 | 34 | 0.340 |
Why?
|
| Hydrops Fetalis | 3 | 2016 | 113 | 0.340 |
Why?
|
| DiGeorge Syndrome | 2 | 2023 | 187 | 0.340 |
Why?
|
| Pregnancy in Adolescence | 1 | 2011 | 164 | 0.330 |
Why?
|
| Temperance | 2 | 2006 | 88 | 0.330 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2018 | 1736 | 0.320 |
Why?
|
| Societies, Medical | 2 | 2020 | 3956 | 0.310 |
Why?
|
| Psychotherapy, Brief | 2 | 2006 | 118 | 0.300 |
Why?
|
| Echocardiography, Doppler | 4 | 2014 | 899 | 0.300 |
Why?
|
| Population Surveillance | 3 | 2015 | 2590 | 0.290 |
Why?
|
| Health Knowledge, Attitudes, Practice | 4 | 2015 | 4058 | 0.290 |
Why?
|
| Neovascularization, Physiologic | 1 | 2015 | 1375 | 0.290 |
Why?
|
| Adult | 60 | 2025 | 223044 | 0.290 |
Why?
|
| Alcoholism | 7 | 2011 | 1975 | 0.280 |
Why?
|
| Placenta Diseases | 4 | 2015 | 199 | 0.270 |
Why?
|
| Atrial Septum | 3 | 2017 | 61 | 0.260 |
Why?
|
| Retrospective Studies | 33 | 2025 | 81514 | 0.260 |
Why?
|
| Ductus Arteriosus | 2 | 2020 | 42 | 0.260 |
Why?
|
| Neck | 1 | 2011 | 733 | 0.260 |
Why?
|
| Decidua | 1 | 2006 | 80 | 0.250 |
Why?
|
| Peptide Fragments | 1 | 2018 | 5125 | 0.240 |
Why?
|
| Cannabis | 1 | 2011 | 446 | 0.240 |
Why?
|
| Delivery, Obstetric | 4 | 2014 | 946 | 0.230 |
Why?
|
| Trophoblasts | 1 | 2006 | 223 | 0.230 |
Why?
|
| Overweight | 1 | 2015 | 2444 | 0.220 |
Why?
|
| Postnatal Care | 2 | 2024 | 275 | 0.220 |
Why?
|
| Diabetes, Gestational | 3 | 2021 | 1263 | 0.220 |
Why?
|
| Puerperal Disorders | 2 | 2024 | 306 | 0.210 |
Why?
|
| Fathers | 1 | 2006 | 376 | 0.210 |
Why?
|
| Communication | 1 | 2017 | 3916 | 0.210 |
Why?
|
| Embolization, Therapeutic | 2 | 2023 | 1403 | 0.210 |
Why?
|
| Mass Screening | 6 | 2017 | 5446 | 0.200 |
Why?
|
| Heart Septal Defects, Atrial | 3 | 2014 | 452 | 0.200 |
Why?
|
| Internal Medicine | 2 | 2023 | 1064 | 0.200 |
Why?
|
| Amniotic Fluid | 2 | 2018 | 380 | 0.200 |
Why?
|
| Genes, Dominant | 1 | 2025 | 856 | 0.190 |
Why?
|
| Galactosemias | 1 | 2023 | 124 | 0.190 |
Why?
|
| Cerebral Veins | 1 | 2023 | 157 | 0.190 |
Why?
|
| In Situ Hybridization, Fluorescence | 4 | 2015 | 2505 | 0.190 |
Why?
|
| Diseases in Twins | 3 | 2015 | 448 | 0.190 |
Why?
|
| Epigenesis, Genetic | 3 | 2015 | 3819 | 0.190 |
Why?
|
| Body Mass Index | 3 | 2021 | 13039 | 0.190 |
Why?
|
| Goals | 1 | 2006 | 719 | 0.180 |
Why?
|
| Chorion | 4 | 2015 | 113 | 0.180 |
Why?
|
| Pandemics | 1 | 2020 | 8703 | 0.180 |
Why?
|
| Abortion, Induced | 2 | 2017 | 471 | 0.180 |
Why?
|
| Behavior Therapy | 1 | 2006 | 884 | 0.170 |
Why?
|
| Embryo Transfer | 2 | 2022 | 525 | 0.170 |
Why?
|
| Infertility | 2 | 2023 | 654 | 0.170 |
Why?
|
| Semen | 1 | 2023 | 354 | 0.170 |
Why?
|
| Blood Circulation | 1 | 2021 | 248 | 0.170 |
Why?
|
| Self Report | 1 | 2011 | 3770 | 0.170 |
Why?
|
| Ebstein Anomaly | 1 | 2020 | 106 | 0.160 |
Why?
|
| General Practitioners | 1 | 2021 | 105 | 0.160 |
Why?
|
| Trisomy | 2 | 2016 | 259 | 0.160 |
Why?
|
| Pulmonary Valve Insufficiency | 1 | 2020 | 140 | 0.160 |
Why?
|
| Substance-Related Disorders | 3 | 2011 | 4416 | 0.150 |
Why?
|
| Hernia, Diaphragmatic | 2 | 2012 | 243 | 0.150 |
Why?
|
| Fetal Blood | 3 | 2023 | 1369 | 0.150 |
Why?
|
| Fetoscopy | 2 | 2009 | 140 | 0.150 |
Why?
|
| Decision Trees | 1 | 2020 | 509 | 0.150 |
Why?
|
| Neural Tube Defects | 2 | 1999 | 256 | 0.150 |
Why?
|
| Hemodynamics | 5 | 2022 | 4184 | 0.150 |
Why?
|
| Monosomy | 1 | 2017 | 52 | 0.150 |
Why?
|
| Maternal Age | 5 | 2010 | 804 | 0.140 |
Why?
|
| Tricuspid Valve | 1 | 2020 | 422 | 0.140 |
Why?
|
| Embryo, Mammalian | 2 | 2021 | 1673 | 0.140 |
Why?
|
| Vascular Malformations | 1 | 2023 | 471 | 0.140 |
Why?
|
| Genetics, Medical | 1 | 2000 | 334 | 0.140 |
Why?
|
| Oligospermia | 1 | 1997 | 61 | 0.140 |
Why?
|
| Cell-Free System | 2 | 2016 | 339 | 0.140 |
Why?
|
| Hypogonadism | 1 | 2023 | 801 | 0.130 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2020 | 363 | 0.130 |
Why?
|
| Teratogens | 1 | 1997 | 121 | 0.130 |
Why?
|
| Microinjections | 1 | 1997 | 320 | 0.130 |
Why?
|
| Physicians, Primary Care | 1 | 2023 | 622 | 0.130 |
Why?
|
| Rh Isoimmunization | 1 | 2016 | 23 | 0.130 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2021 | 521 | 0.130 |
Why?
|
| Birth Weight | 3 | 2014 | 2121 | 0.130 |
Why?
|
| Abnormalities, Multiple | 4 | 2013 | 1424 | 0.130 |
Why?
|
| Choice Behavior | 2 | 2016 | 844 | 0.130 |
Why?
|
| Patient Education as Topic | 2 | 2006 | 2334 | 0.130 |
Why?
|
| Face | 3 | 2001 | 1028 | 0.120 |
Why?
|
| Indomethacin | 2 | 2020 | 322 | 0.120 |
Why?
|
| Triploidy | 1 | 2014 | 3 | 0.120 |
Why?
|
| Fetal Resorption | 1 | 2014 | 15 | 0.120 |
Why?
|
| Sensitivity and Specificity | 7 | 2018 | 14652 | 0.120 |
Why?
|
| Abnormalities, Drug-Induced | 2 | 1997 | 335 | 0.120 |
Why?
|
| False Positive Reactions | 2 | 2015 | 955 | 0.120 |
Why?
|
| Coronary Circulation | 2 | 2018 | 1602 | 0.120 |
Why?
|
| Clinical Competence | 2 | 2021 | 4863 | 0.120 |
Why?
|
| Polycystic Kidney, Autosomal Recessive | 1 | 2014 | 31 | 0.120 |
Why?
|
| Ovary | 2 | 2023 | 956 | 0.120 |
Why?
|
| Vascular Diseases | 1 | 2023 | 1159 | 0.110 |
Why?
|
| Fertilization | 1 | 2015 | 197 | 0.110 |
Why?
|
| Maple Syrup Urine Disease | 1 | 2014 | 41 | 0.110 |
Why?
|
| Adolescent | 12 | 2019 | 88835 | 0.110 |
Why?
|
| Pregnancy Trimester, Second | 4 | 2013 | 737 | 0.110 |
Why?
|
| Nucleotides | 1 | 2016 | 451 | 0.110 |
Why?
|
| Nasal Bone | 1 | 2013 | 58 | 0.110 |
Why?
|
| Cesarean Section | 4 | 2014 | 1431 | 0.110 |
Why?
|
| Predictive Value of Tests | 9 | 2021 | 15398 | 0.110 |
Why?
|
| Obesity | 2 | 2015 | 13076 | 0.110 |
Why?
|
| Phenotype | 5 | 2021 | 16721 | 0.110 |
Why?
|
| Amnion | 2 | 2011 | 204 | 0.110 |
Why?
|
| Pleural Effusion | 1 | 1997 | 346 | 0.110 |
Why?
|
| Attitude of Health Personnel | 2 | 2013 | 3925 | 0.110 |
Why?
|
| Cardiovascular Diseases | 2 | 2019 | 15652 | 0.110 |
Why?
|
| Ambulatory Care Facilities | 1 | 2019 | 939 | 0.110 |
Why?
|
| Young Adult | 9 | 2019 | 59889 | 0.110 |
Why?
|
| Extracorporeal Membrane Oxygenation | 3 | 2012 | 1480 | 0.110 |
Why?
|
| Program Development | 1 | 2019 | 1295 | 0.110 |
Why?
|
| Risk Factors | 16 | 2021 | 74840 | 0.110 |
Why?
|
| Spermatozoa | 1 | 1997 | 629 | 0.100 |
Why?
|
| Qualitative Research | 1 | 2024 | 3139 | 0.100 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2012 | 3797 | 0.100 |
Why?
|
| Multifactorial Inheritance | 1 | 2021 | 1425 | 0.100 |
Why?
|
| CHARGE Syndrome | 1 | 2012 | 34 | 0.100 |
Why?
|
| Genomic Library | 1 | 2012 | 189 | 0.100 |
Why?
|
| Hydatidiform Mole | 1 | 2014 | 255 | 0.100 |
Why?
|
| Statistics, Nonparametric | 4 | 2013 | 2844 | 0.100 |
Why?
|
| Stem Cell Transplantation | 1 | 2020 | 1602 | 0.100 |
Why?
|
| Patient Care Team | 1 | 2023 | 2517 | 0.090 |
Why?
|
| Lactation | 1 | 2014 | 391 | 0.090 |
Why?
|
| Anencephaly | 1 | 1991 | 20 | 0.090 |
Why?
|
| Medical History Taking | 1 | 2015 | 777 | 0.090 |
Why?
|
| Gene Rearrangement | 1 | 2016 | 1144 | 0.090 |
Why?
|
| Fetal Death | 4 | 2004 | 435 | 0.090 |
Why?
|
| International Cooperation | 2 | 2015 | 1432 | 0.090 |
Why?
|
| Hepatitis B | 1 | 1996 | 707 | 0.090 |
Why?
|
| Treatment Outcome | 20 | 2022 | 65188 | 0.090 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2018 | 3655 | 0.090 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 2268 | 0.090 |
Why?
|
| Male | 31 | 2023 | 363698 | 0.090 |
Why?
|
| Case-Control Studies | 7 | 2015 | 22223 | 0.090 |
Why?
|
| Infant, Low Birth Weight | 1 | 2015 | 871 | 0.090 |
Why?
|
| Endocardial Fibroelastosis | 1 | 2010 | 66 | 0.090 |
Why?
|
| Chorionic Villi | 3 | 1995 | 53 | 0.090 |
Why?
|
| CpG Islands | 1 | 2015 | 1207 | 0.090 |
Why?
|
| Cytogenetic Analysis | 1 | 2011 | 269 | 0.090 |
Why?
|
| Fetofetal Transfusion | 3 | 2015 | 119 | 0.080 |
Why?
|
| Tocolytic Agents | 1 | 2009 | 24 | 0.080 |
Why?
|
| Patient Readmission | 1 | 2024 | 3286 | 0.080 |
Why?
|
| Antihypertensive Agents | 1 | 2019 | 2033 | 0.080 |
Why?
|
| Microcephaly | 1 | 1994 | 426 | 0.080 |
Why?
|
| Video-Assisted Surgery | 1 | 2009 | 48 | 0.080 |
Why?
|
| Echocardiography, Doppler, Color | 2 | 2009 | 353 | 0.080 |
Why?
|
| Ultrasonography, Doppler | 3 | 2020 | 460 | 0.080 |
Why?
|
| Gametogenesis | 1 | 2009 | 27 | 0.080 |
Why?
|
| Optical Phenomena | 1 | 2009 | 103 | 0.080 |
Why?
|
| Comorbidity | 2 | 2017 | 10563 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 1 | 2018 | 6069 | 0.080 |
Why?
|
| Parents | 1 | 2022 | 3592 | 0.080 |
Why?
|
| Lipids | 2 | 2021 | 3315 | 0.080 |
Why?
|
| Twins, Monozygotic | 1 | 2010 | 469 | 0.080 |
Why?
|
| Ultrasonography, Interventional | 2 | 2023 | 1531 | 0.080 |
Why?
|
| Massachusetts | 3 | 2013 | 8875 | 0.070 |
Why?
|
| Aortic Valve | 3 | 2009 | 1968 | 0.070 |
Why?
|
| Follow-Up Studies | 11 | 2014 | 39193 | 0.070 |
Why?
|
| Risk | 2 | 2017 | 9591 | 0.070 |
Why?
|
| Ventricular Function | 1 | 2009 | 403 | 0.070 |
Why?
|
| Heart Septum | 1 | 2008 | 303 | 0.070 |
Why?
|
| Obstetric Labor, Premature | 2 | 2010 | 268 | 0.070 |
Why?
|
| Chi-Square Distribution | 2 | 2006 | 3432 | 0.070 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2017 | 3675 | 0.070 |
Why?
|
| Infant, Premature | 3 | 2004 | 2122 | 0.070 |
Why?
|
| Cystic Adenomatoid Malformation of Lung, Congenital | 1 | 2007 | 42 | 0.070 |
Why?
|
| Recurrence | 1 | 2019 | 8501 | 0.070 |
Why?
|
| Social Facilitation | 1 | 2006 | 31 | 0.070 |
Why?
|
| Risk Assessment | 10 | 2020 | 24282 | 0.070 |
Why?
|
| Prospective Studies | 5 | 2022 | 54802 | 0.070 |
Why?
|
| Primary Health Care | 1 | 2023 | 4736 | 0.070 |
Why?
|
| Boston | 3 | 2017 | 9338 | 0.060 |
Why?
|
| Genetic Variation | 1 | 2021 | 6610 | 0.060 |
Why?
|
| Reference Values | 3 | 2006 | 4908 | 0.060 |
Why?
|
| Perinatal Mortality | 2 | 2020 | 103 | 0.060 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 1999 | 2531 | 0.060 |
Why?
|
| Live Birth | 2 | 2020 | 516 | 0.060 |
Why?
|
| Perinatology | 1 | 2005 | 64 | 0.060 |
Why?
|
| Hypertension | 2 | 2023 | 8626 | 0.060 |
Why?
|
| Twinning, Monozygotic | 2 | 2015 | 17 | 0.060 |
Why?
|
| Habits | 1 | 2006 | 147 | 0.060 |
Why?
|
| Blood Glucose | 2 | 2021 | 6424 | 0.060 |
Why?
|
| Developmental Disabilities | 1 | 1994 | 1519 | 0.060 |
Why?
|
| Thoracotomy | 1 | 2007 | 369 | 0.060 |
Why?
|
| Cohort Studies | 7 | 2021 | 41649 | 0.060 |
Why?
|
| Nurse-Patient Relations | 1 | 2005 | 102 | 0.060 |
Why?
|
| Infarction | 1 | 2006 | 246 | 0.060 |
Why?
|
| Heart Atria | 1 | 2011 | 1363 | 0.060 |
Why?
|
| Drug Tolerance | 1 | 2006 | 363 | 0.060 |
Why?
|
| Probability | 3 | 2023 | 2475 | 0.060 |
Why?
|
| ROC Curve | 3 | 2010 | 3620 | 0.060 |
Why?
|
| Family | 1 | 2015 | 3209 | 0.060 |
Why?
|
| Echocardiography | 2 | 2020 | 5045 | 0.050 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2006 | 291 | 0.050 |
Why?
|
| Lymphatic System | 1 | 2005 | 250 | 0.050 |
Why?
|
| Maternal Behavior | 1 | 2006 | 306 | 0.050 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 2004 | 137 | 0.050 |
Why?
|
| Pilot Projects | 3 | 2012 | 8733 | 0.050 |
Why?
|
| Infant, Premature, Diseases | 1 | 2009 | 713 | 0.050 |
Why?
|
| HELLP Syndrome | 2 | 2006 | 41 | 0.050 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2011 | 2136 | 0.050 |
Why?
|
| Time Factors | 5 | 2020 | 40065 | 0.050 |
Why?
|
| Teratoma | 1 | 2005 | 401 | 0.050 |
Why?
|
| Stents | 1 | 2014 | 3213 | 0.050 |
Why?
|
| Ethics Committees, Research | 1 | 2023 | 197 | 0.050 |
Why?
|
| Middle Cerebral Artery | 2 | 2015 | 268 | 0.050 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2011 | 1414 | 0.050 |
Why?
|
| Heparan Sulfate Proteoglycans | 1 | 2001 | 111 | 0.050 |
Why?
|
| Logistic Models | 3 | 2021 | 13266 | 0.050 |
Why?
|
| Constriction | 1 | 2020 | 166 | 0.040 |
Why?
|
| Ultrasonography | 4 | 2023 | 5993 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2015 | 4424 | 0.040 |
Why?
|
| Twins, Conjoined | 1 | 2000 | 41 | 0.040 |
Why?
|
| Infant | 6 | 2023 | 36386 | 0.040 |
Why?
|
| Gene Expression | 1 | 1993 | 7584 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2001 | 313 | 0.040 |
Why?
|
| Risk-Taking | 1 | 2005 | 1021 | 0.040 |
Why?
|
| Airway Obstruction | 1 | 2005 | 665 | 0.040 |
Why?
|
| Cerebrovascular Circulation | 1 | 2010 | 2674 | 0.040 |
Why?
|
| Blood Pressure | 1 | 2015 | 8532 | 0.040 |
Why?
|
| Fatty Liver | 1 | 2006 | 807 | 0.040 |
Why?
|
| Dystocia | 1 | 1999 | 33 | 0.040 |
Why?
|
| Vinblastine | 1 | 2001 | 483 | 0.040 |
Why?
|
| Middle Aged | 8 | 2019 | 223009 | 0.040 |
Why?
|
| Mutation | 4 | 2012 | 30198 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2001 | 533 | 0.040 |
Why?
|
| Microarray Analysis | 1 | 2022 | 752 | 0.040 |
Why?
|
| Health Education | 1 | 2006 | 1060 | 0.040 |
Why?
|
| Ibuprofen | 1 | 2020 | 228 | 0.040 |
Why?
|
| Registries | 1 | 2015 | 8297 | 0.040 |
Why?
|
| Models, Animal | 1 | 2005 | 2120 | 0.040 |
Why?
|
| Translocation, Genetic | 2 | 2016 | 1394 | 0.040 |
Why?
|
| Cervical Vertebrae | 1 | 2005 | 974 | 0.040 |
Why?
|
| Co-Repressor Proteins | 1 | 2019 | 187 | 0.040 |
Why?
|
| Heart Failure | 1 | 2023 | 11840 | 0.040 |
Why?
|
| Chorionic Villi Sampling | 2 | 2001 | 35 | 0.040 |
Why?
|
| Spinal Neoplasms | 1 | 2005 | 708 | 0.040 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2001 | 258 | 0.040 |
Why?
|
| Maternal Exposure | 1 | 2006 | 1095 | 0.040 |
Why?
|
| Lung | 1 | 2017 | 10033 | 0.040 |
Why?
|
| Abdominal Muscles | 1 | 1999 | 172 | 0.040 |
Why?
|
| Self Disclosure | 1 | 1999 | 248 | 0.040 |
Why?
|
| Fertility | 1 | 2023 | 768 | 0.040 |
Why?
|
| Genome, Human | 3 | 2016 | 4448 | 0.040 |
Why?
|
| Reproducibility of Results | 6 | 2013 | 20124 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2014 | 14751 | 0.040 |
Why?
|
| Income | 1 | 2006 | 1874 | 0.030 |
Why?
|
| Heart Ventricles | 1 | 2009 | 3832 | 0.030 |
Why?
|
| Counseling | 1 | 2005 | 1551 | 0.030 |
Why?
|
| Estriol | 1 | 1996 | 53 | 0.030 |
Why?
|
| Obstetric Labor Complications | 1 | 1999 | 240 | 0.030 |
Why?
|
| Central Nervous System Depressants | 1 | 1998 | 163 | 0.030 |
Why?
|
| Blood Pressure Determination | 1 | 2021 | 647 | 0.030 |
Why?
|
| Acidosis, Renal Tubular | 1 | 1997 | 50 | 0.030 |
Why?
|
| Vesicular Transport Proteins | 1 | 2019 | 376 | 0.030 |
Why?
|
| Chromosome Mapping | 2 | 2016 | 4618 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2005 | 6203 | 0.030 |
Why?
|
| Interviews as Topic | 1 | 2024 | 2739 | 0.030 |
Why?
|
| Growth Disorders | 1 | 2001 | 633 | 0.030 |
Why?
|
| Cross-Sectional Studies | 3 | 2015 | 26318 | 0.030 |
Why?
|
| Premature Birth | 1 | 2009 | 1829 | 0.030 |
Why?
|
| Pregnancy Trimester, Third | 2 | 2013 | 587 | 0.030 |
Why?
|
| Postoperative Complications | 2 | 2017 | 15747 | 0.030 |
Why?
|
| SOX9 Transcription Factor | 1 | 2016 | 146 | 0.030 |
Why?
|
| Social Support | 1 | 2006 | 2192 | 0.030 |
Why?
|
| Suction | 1 | 1997 | 265 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2016 | 191 | 0.030 |
Why?
|
| DNA Probes | 1 | 1996 | 541 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2016 | 247 | 0.030 |
Why?
|
| Clinical Trials as Topic | 2 | 2023 | 8041 | 0.030 |
Why?
|
| Paraffin Embedding | 1 | 1996 | 301 | 0.030 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 1996 | 294 | 0.030 |
Why?
|
| Respiration, Artificial | 1 | 2007 | 2709 | 0.030 |
Why?
|
| Incidence | 3 | 2013 | 21480 | 0.030 |
Why?
|
| Child, Preschool | 5 | 2020 | 42500 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2014 | 16047 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 2 | 2016 | 4772 | 0.030 |
Why?
|
| False Negative Reactions | 1 | 2016 | 573 | 0.030 |
Why?
|
| Patient Compliance | 1 | 2005 | 2692 | 0.030 |
Why?
|
| Fasting | 1 | 2021 | 1606 | 0.030 |
Why?
|
| Chorionic Gonadotropin | 1 | 1996 | 457 | 0.030 |
Why?
|
| Health Behavior | 1 | 2006 | 2650 | 0.030 |
Why?
|
| Parity | 2 | 2010 | 931 | 0.030 |
Why?
|
| Ploidies | 1 | 1995 | 287 | 0.030 |
Why?
|
| Polycythemia | 1 | 2015 | 125 | 0.030 |
Why?
|
| Administration, Inhalation | 1 | 1997 | 1154 | 0.030 |
Why?
|
| Patient Care Planning | 1 | 1999 | 906 | 0.030 |
Why?
|
| Educational Status | 1 | 2021 | 2513 | 0.030 |
Why?
|
| Health Care Surveys | 1 | 2021 | 2424 | 0.030 |
Why?
|
| Glucose Tolerance Test | 1 | 1996 | 1180 | 0.030 |
Why?
|
| Barotrauma | 1 | 2012 | 40 | 0.030 |
Why?
|
| Nutritional Requirements | 1 | 2014 | 276 | 0.020 |
Why?
|
| Cytoplasm | 1 | 1997 | 1500 | 0.020 |
Why?
|
| Thrombosis | 1 | 2006 | 2949 | 0.020 |
Why?
|
| Specimen Handling | 1 | 1996 | 704 | 0.020 |
Why?
|
| Fragile X Syndrome | 1 | 1993 | 116 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2005 | 12056 | 0.020 |
Why?
|
| Primary Prevention | 1 | 2019 | 1187 | 0.020 |
Why?
|
| Ethanol | 1 | 1998 | 1323 | 0.020 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2014 | 266 | 0.020 |
Why?
|
| Animals | 6 | 2023 | 168764 | 0.020 |
Why?
|
| Hypertrophy | 1 | 2013 | 559 | 0.020 |
Why?
|
| Lung Volume Measurements | 1 | 2012 | 381 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2015 | 12240 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2022 | 5302 | 0.020 |
Why?
|
| Women's Health | 1 | 2000 | 2084 | 0.020 |
Why?
|
| Child | 5 | 2020 | 80564 | 0.020 |
Why?
|
| Edema | 1 | 1995 | 760 | 0.020 |
Why?
|
| Gene Deletion | 2 | 2001 | 2666 | 0.020 |
Why?
|
| Primates | 1 | 1993 | 518 | 0.020 |
Why?
|
| Genes, Recessive | 1 | 1993 | 624 | 0.020 |
Why?
|
| Incidental Findings | 1 | 2015 | 697 | 0.020 |
Why?
|
| Disease Progression | 2 | 2020 | 13632 | 0.020 |
Why?
|
| Education, Medical, Continuing | 1 | 2015 | 830 | 0.020 |
Why?
|
| Mesoderm | 1 | 1993 | 679 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2020 | 2966 | 0.020 |
Why?
|
| Umbilical Arteries | 1 | 2010 | 78 | 0.020 |
Why?
|
| Surgical Mesh | 1 | 2012 | 315 | 0.020 |
Why?
|
| Parenteral Nutrition | 1 | 2014 | 660 | 0.020 |
Why?
|
| Expert Testimony | 1 | 2011 | 266 | 0.020 |
Why?
|
| Administration, Oral | 1 | 1997 | 4015 | 0.020 |
Why?
|
| Diastole | 1 | 2011 | 785 | 0.020 |
Why?
|
| Prognosis | 1 | 2009 | 29922 | 0.020 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2014 | 587 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2023 | 36532 | 0.020 |
Why?
|
| Spectrum Analysis | 1 | 2009 | 443 | 0.020 |
Why?
|
| Odds Ratio | 2 | 2013 | 9649 | 0.020 |
Why?
|
| Life Style | 1 | 2019 | 3926 | 0.020 |
Why?
|
| Anthropometry | 1 | 2012 | 1338 | 0.020 |
Why?
|
| Maternal Mortality | 1 | 2010 | 313 | 0.020 |
Why?
|
| Public Opinion | 1 | 2011 | 482 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2014 | 2105 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2000 | 6255 | 0.020 |
Why?
|
| Skull | 1 | 1991 | 811 | 0.020 |
Why?
|
| Occupational Exposure | 1 | 1997 | 1805 | 0.020 |
Why?
|
| Health Planning Guidelines | 1 | 2007 | 151 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 1997 | 4247 | 0.020 |
Why?
|
| Neoplasms | 1 | 2015 | 22340 | 0.020 |
Why?
|
| Energy Intake | 1 | 2014 | 2141 | 0.020 |
Why?
|
| Heart Transplantation | 1 | 2020 | 3310 | 0.020 |
Why?
|
| Patient Selection | 1 | 2018 | 4255 | 0.020 |
Why?
|
| Constriction, Pathologic | 1 | 2009 | 1105 | 0.020 |
Why?
|
| Physician-Patient Relations | 1 | 1999 | 3278 | 0.020 |
Why?
|
| Ambulatory Care | 1 | 1996 | 2778 | 0.020 |
Why?
|
| Alleles | 1 | 2016 | 6897 | 0.020 |
Why?
|
| Consensus | 1 | 2015 | 3202 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2009 | 1816 | 0.010 |
Why?
|
| Severity of Illness Index | 3 | 2007 | 15880 | 0.010 |
Why?
|
| Education | 1 | 2007 | 533 | 0.010 |
Why?
|
| Brain | 1 | 1991 | 27171 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 1997 | 5526 | 0.010 |
Why?
|
| Head | 1 | 2010 | 925 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 6499 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2001 | 6364 | 0.010 |
Why?
|
| United States | 3 | 2023 | 72903 | 0.010 |
Why?
|
| Linear Models | 1 | 2013 | 5876 | 0.010 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2001 | 5389 | 0.010 |
Why?
|
| Demography | 1 | 2006 | 1641 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2021 | 12807 | 0.010 |
Why?
|
| Canada | 1 | 2007 | 2119 | 0.010 |
Why?
|
| Chromosome Painting | 1 | 2001 | 26 | 0.010 |
Why?
|
| Glypicans | 1 | 2001 | 33 | 0.010 |
Why?
|
| Lymphangioma, Cystic | 1 | 2001 | 34 | 0.010 |
Why?
|
| Chromosome Banding | 1 | 2001 | 261 | 0.010 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2005 | 575 | 0.010 |
Why?
|
| Bronchoscopy | 1 | 2007 | 909 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 2001 | 772 | 0.010 |
Why?
|
| Genomics | 1 | 2016 | 5929 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2006 | 2910 | 0.010 |
Why?
|
| Prevalence | 1 | 1997 | 15842 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2001 | 11868 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 11888 | 0.010 |
Why?
|
| Genotype | 1 | 1993 | 13024 | 0.010 |
Why?
|
| Fatty Acids | 1 | 2006 | 1806 | 0.010 |
Why?
|
| Sampling Studies | 1 | 1999 | 607 | 0.010 |
Why?
|
| X Chromosome | 1 | 2001 | 819 | 0.010 |
Why?
|
| Apoptosis | 1 | 2013 | 9514 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 1997 | 18293 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 1999 | 18071 | 0.010 |
Why?
|
| Personality Inventory | 1 | 2000 | 1018 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2014 | 7425 | 0.010 |
Why?
|
| Family Health | 1 | 2001 | 1253 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2001 | 13451 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 2001 | 2341 | 0.010 |
Why?
|
| Mice | 1 | 2023 | 81819 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2010 | 12976 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2008 | 6404 | 0.010 |
Why?
|
| Syndrome | 1 | 2001 | 3271 | 0.010 |
Why?
|
| Mental Health Services | 1 | 2006 | 1723 | 0.010 |
Why?
|
| Models, Biological | 1 | 2011 | 9443 | 0.010 |
Why?
|
| Cisplatin | 1 | 2001 | 1658 | 0.010 |
Why?
|
| Survival Rate | 1 | 2008 | 12795 | 0.010 |
Why?
|
| Heart | 1 | 2007 | 4414 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2007 | 10070 | 0.010 |
Why?
|
| Pedigree | 1 | 2001 | 4526 | 0.010 |
Why?
|
| Yolk Sac | 1 | 1993 | 79 | 0.010 |
Why?
|
| Observer Variation | 1 | 1999 | 2615 | 0.010 |
Why?
|
| Dyspnea | 1 | 2001 | 1352 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2000 | 21056 | 0.010 |
Why?
|
| Oxygen | 1 | 2001 | 4241 | 0.000 |
Why?
|
| Pneumonia | 1 | 2001 | 2157 | 0.000 |
Why?
|
| Socioeconomic Factors | 1 | 1999 | 7838 | 0.000 |
Why?
|
| Smoking | 1 | 2001 | 9081 | 0.000 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2000 | 8923 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 1993 | 11641 | 0.000 |
Why?
|